Allogeneic Stem Cell Transplant Feasible for Leukemia in Elderly Patients

TUESDAY, Feb. 21, 2023 -- In elderly adults aged 60 years and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), allogeneic hematopoietic stem cell transplant (HSCT) can be performed with acceptable overall survival and...